Alcon Expands Glaucoma Portfolio Into Surgical Devices With Optonol Buy
This article was originally published in The Gray Sheet
Alcon will enter the surgical glaucoma market with its acquisition of Israel-based Optonol, maker of miniature implants to reduce intraocular pressure
You may also be interested in...
Alcon says it is looking to leverage short-term opportunities to grow its surgical business
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.